Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Xeris Pharmaceuticals, Inc 8.3

24th Aug 2021 14:10

RNS Number : 6411J

J.P. Morgan Securities LLC

24 August 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	J.P. Morgan Securities LLC
Company dealt in	Xeris Pharmaceuticals, Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)	$0.001 common stock
Date of dealing	23 August 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	1,873,510 2.82		35,070 0.05
(2) Derivatives (other than options)	0.00		0.00
(3) Options and agreements to purchase/sell	0.00		0.00
Total	1,873,510 2.82		35,070 0.05

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (USD)

(Note 5)

Sale (Borrow Return)

Sale (New Loan)

Purchase

Sale

147,300

22,100

900

600

208

18,350

807

21,346

20,452

113,849

300

44,441

7,945

300

128

101

900

113,849

#N/A

2.4867 USD

2.4875 USD

2.4925 USD

2.5000 USD

2.5067 USD

2.5100 USD

2.5133 USD

2.5150 USD

2.5240 USD

2.5300 USD

2.5325 USD

2.5343 USD

2.5368 USD

2.5400 USD

2.5425 USD

2.5433 USD

2.5436 USD

2.5467 USD

2.5500 USD

2.5520 USD

2.5550 USD

2.5553 USD

2.5567 USD

2.5593 USD

2.5600 USD

2.5633 USD

2.5647 USD

2.5650 USD

2.5667 USD

2.5700 USD

2.5714 USD

2.5733 USD

2.5740 USD

2.5743 USD

2.5750 USD

2.5754 USD

2.5757 USD

2.5800 USD

2.5830 USD

2.5850 USD

2.5857 USD

2.5867 USD

2.5900 USD

2.5913 USD

2.5914 USD

2.5950 USD

2.5970 USD

2.5988 USD

2.6000 USD

2.6014 USD

2.6015 USD

2.6050 USD

2.6100 USD

2.6144 USD

2.6150 USD

2.6200 USD

2.6300 USD

2.6343 USD

2.6350 USD

2.6450 USD

2.6559 USD

2.6800 USD

2.7218 USD

2.7300 USD

2.7400 USD

2.7406 USD

2.7596 USD

2.7802 USD

2.8044 USD

2.8085 USD

2.8100 USD

2.8361 USD

2.8430 USD

2.8452 USD

2.8462 USD

2.8502 USD

2.8553 USD

2.8615 USD

2.8700 USD

2.4800 USD

2.4867 USD

2.4875 USD

2.4925 USD

2.5000 USD

2.5067 USD

2.5100 USD

2.5133 USD

2.5150 USD

2.5200 USD

2.5240 USD

2.5283 USD

2.5300 USD

2.5325 USD

2.5343 USD

2.5368 USD

2.5400 USD

2.5425 USD

2.5433 USD

2.5436 USD

2.5467 USD

2.5471 USD

2.5491 USD

2.5500 USD

2.5520 USD

2.5537 USD

2.5550 USD

2.5553 USD

2.5567 USD

2.5586 USD

2.5593 USD

2.5600 USD

2.5633 USD

2.5638 USD

2.5647 USD

2.5650 USD

2.5667 USD

2.5700 USD

2.5714 USD

2.5717 USD

2.5722 USD

2.5733 USD

2.5740 USD

2.5743 USD

2.5750 USD

2.5754 USD

2.5757 USD

2.5760 USD

2.5775 USD

2.5793 USD

2.5797 USD

2.5800 USD

2.5830 USD

2.5847 USD

2.5850 USD

2.5857 USD

2.5867 USD

2.5900 USD

2.5913 USD

2.5914 USD

2.5936 USD

2.5950 USD

2.5963 USD

2.5970 USD

2.5972 USD

2.5988 USD

2.6000 USD

2.6014 USD

2.6015 USD

2.6050 USD

2.6100 USD

2.6144 USD

2.6150 USD

2.6200 USD

2.6300 USD

2.6343 USD

2.6346 USD

2.6350 USD

2.6400 USD

2.6450 USD

2.6500 USD

2.6559 USD

2.6700 USD

2.6800 USD

2.7218 USD

2.7300 USD

2.7400 USD

2.7406 USD

2.7433 USD

2.7454 USD

2.7596 USD

2.8100 USD

2.8462 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(USD) (Note 5)

Equity Swap

Decrease Long

113,849

2.8462 USD

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of anyrelevant securities to which any derivative referred to on this form is referenced. If none, thisshould be stated.

None

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure	24 August 2021
Contact name	Alwyn Basch
Telephone number	0207 742 7407
If a connected EFM, name of offeree/offeror with which connected	N/A
If a connected EFM, state nature of connection (Note 10)	N/A

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEPPURURUPGGWC

Related Shares:

FTSE 100 Latest

Value8,621.83

Change79.27